FDA APPROVES LEQEMBI IQLIK® (LECANEMAB-IRMB) SUBCUTANEOUS INJECTION AS AN INITIATION DOSE FOR EARLY ALZHEIMER'S DISEASE

Reuters · 1d ago

Please log in to view news